期刊文献+

阿仑膦酸钠对骨关节炎关节软骨保护作用的研究进展 被引量:5

RESEARCH PROGRESS OF PROTECTIVE EFFECTS OF ALENDRONATE ON ARTICULAR CARTILAGE IN OSTEOARTHRITIS
原文传递
导出
摘要 目的综述阿仑膦酸钠(alendronate,ALN)对骨关节炎(osteoarthritis,OA)关节软骨保护作用的研究进展。方法广泛查阅近年国内外相关文献,并进行综合分析。结果 ALN能改善OA关节软骨代谢微环境,抑制软骨下骨骨重塑,对关节软骨有潜在保护作用。结论 ALN有望成为一种OA疾病改善药物,但OA治疗尚缺乏统一的基础与临床评价标准,制定统一标准并获取临床数据对ALN的开发和应用有指导性意义。 Objective To summarize the recent development on chondroprotective effect of alendronate(ALN) on articular cartilage in osteoarthritis(OA).Methods The related literature was reviewed and the main achievements in vitro/vivo studies in the fields were summarized.Results ALN can improve the metabolic microenvironment of the articular cartilage in OA,inhibit subchondral bone remodeling,so it has potential protective effect on articular cartilage.Conclusion ALN is expected to become a disease-modifying OA drug in future,but OA treatment still lack a uniform basic and clinical evaluation criteria,so it has guiding signi cance in development and flapplication of ALN to develope a uniform standard and obtain the clinical data.
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2012年第10期1187-1190,共4页 Chinese Journal of Reparative and Reconstructive Surgery
关键词 骨关节炎 阿仑膦酸钠 软骨保护作用 Osteoarthritis Alendronate Cartilage protective effect
  • 相关文献

参考文献22

  • 1Samuels J, Krasnokutsky S, Abramson SB. Osteoarthritis: a tale of threeissues. Bull NYU Hosp Jt Dis, 2008,66(3): 244-250.
  • 2王哲彦,王文雅,张柳.骨性关节炎的发病机制及其与Wnt/β-catenin信号通路的关系[J].中国矫形外科杂志,2009,17(23):1800-1803. 被引量:6
  • 3Hayami T, Pickarski M, Zhuo Y, et al. Characterization of articularcartilage and subchondral bone changes in the rat anterior cruciateligament transection and meniscectomized models of osteoarthritis.Bone, 2006, 38(2): 234-243.
  • 4Qvist P, Bay-Jensen AC, Christiansen C, et al. The disease modifyingosteoarthritis drug (DMOAD): Is it in the horizon. Pharmacol Res,2008,58(1): 1-7.
  • 5Ding M, Danielsen CC, Hvid I. The effects of bone remodeling in-hibition by alendronate on three-dimensional microarchitecture ofsubchondral bone tissues in guinea pig primary osteoarthrosis. CalcifTissue Int, 2008, 82(1): 77-86.
  • 6Konttinen YT, Salo T,Hanemaaijer R, et al. Collagenase-3 (MMP-13)and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol, 1999,18(4):401-412.
  • 7HeikkilS P, Teronen O, Moilanen M,et al. Bisphosphonates inhibitstromelysin-l(MMP-3), matrix metalloelastase (MMP-12), collage-nase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-typeplasminogen activator, and diminish invasion and migration of humanmalignant and endothelial cell lines. Anticancer Drugs, 2002, 13(3):245-254.
  • 8胡宏宇,张柳,李彬,张尹娜,刘晓宁,田发明,程潭,王哲彦.阿仑膦酸钠体外对软骨细胞的影响及对兔前交叉韧带切断后关节软骨和软骨下骨的作用[J].中国修复重建外科杂志,2009,23(12):1474-1481. 被引量:2
  • 9王哲彦,王文雅,张柳,田发明,程潭,杨林.阿仑膦酸钠对IL-1β体外诱导培养的大鼠膝关节软骨细胞影响的实验研究[J].中国修复重建外科杂志,2011,25(1):50-55. 被引量:17
  • 10Hayami T, Pickarski M, Wesolowski GA, et al. The role of subchondralbone remodeling in osteoarthritis: reduction of cartilage degenera-tion and prevention of osteophyte formation by alendronate in the ratanterior cruciate ligament transection model. Arthritis Rheum, 2004,50(4): 1193-1206.

二级参考文献152

共引文献40

同被引文献71

  • 1唐福林,张奉春,郑文洁,李军,栗占国,苏茵,吴东海,马丽,周惠琼,黄烽,张江林,周乙雄,徐辉.双醋瑞因治疗膝骨关节炎的疗效与安全性多中心对照研究[J].中华风湿病学杂志,2005,9(7):421-424. 被引量:62
  • 2牟健雄,沈彬.二磷酸盐骨科临床应用的研究进展[J].中国矫形外科杂志,2007,15(1):42-45. 被引量:4
  • 3李忠,杨柳,戴刚,陈光兴,鲁晓波,阳运康,张卫东,张洪鑫,王晓宇.关节镜下半月板部分切除制备骨关节炎动物模型[J].第三军医大学学报,2007,29(10):919-921. 被引量:20
  • 4SA WITZKE AD, SHI H, FINCO M F, et al. Clinical efficacy and safety of glucosamine, chondrotin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT [ J] . Ann Rheum Dis,2010,69(8) :1459-1464.
  • 5WANDEL S, JUNI P, TENDAL B, et al. Effects of glucosamine , chondroitin or placebo in patients with osteoarthritis of hip or knee: network meta-analysis [J]. BMJ,2010,341 (24) :4675.
  • 6HOCHBERG M C, ALTMAN R D, APRIL K T, et al. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee [J]. Arthritis Care Res( Hoboken) ,2012 ,64( 4) :465-474.
  • 7PETERSON S G, SAXNE T, HEINEGARD D, et al. Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training [ J] . Osteoarth Cart,2010,18(1) :34-40.
  • 8PECCHI E, PRIAM S, MU IlF,NOVIC Z, et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E2 and matrix metalloproteinases synthesis in interleukin-1β stimulated osteoblasts [J]. Osteoarth Cart, 2012 ,20 ( 2) : 127 -135.
  • 9American Academy of Orthopaedic Surgeons (2013 ) . Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd [ EB/OL ]. [2013 - 05 - 18]. http://www. aaos. org/ research/guidelines/GuidelineOAKnee. asp.
  • 10RAILHAC J J, ZAIM M, SAUREL AS, et al. Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI [J]. Clin Rheumatol ,2012 ,31 (9) : 1347 -1357.

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部